ezetimibe has been researched along with alpha-carotene in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (alpha-carotene) | Trials (alpha-carotene) | Recent Studies (post-2010) (alpha-carotene) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 434 | 56 | 179 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, HD; During, A; Harrison, EH | 1 |
1 other study(ies) available for ezetimibe and alpha-carotene
| Article | Year |
|---|---|
Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe.
Topics: Antibodies; Anticholesteremic Agents; Antioxidants; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Azetidines; beta Carotene; Biological Transport, Active; Caco-2 Cells; Carbon Radioisotopes; Carotenoids; CD36 Antigens; Cholesterol; Down-Regulation; Ezetimibe; Gene Expression; Humans; Intestine, Small; Membrane Proteins; Membrane Transport Proteins; Proteins; Scavenger Receptors, Class B; Transcriptional Activation; Vitamin A | 2005 |